Black Diamond Therapeutics, Inc. (BDTX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Join SI Premium – FREE
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q2 EPS of ($0.52), $0.02 better than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- NetApp (NTAP) Tops Q1 EPS by 47c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
